---
title: Improve balance using Segway training
nct_id: NCT05982730
phase: NA
status: RECRUITING
sponsor: University of Texas Southwestern Medical Center
study_type: INTERVENTIONAL
canonical_url: "https://parkinsonspathways.com/trial/NCT05982730"
clinicaltrials_gov: "https://clinicaltrials.gov/study/NCT05982730"
last_fetched: "2026-05-10T14:03:45.016Z"
source: "Parkinson's Pathways (curated)"
---
# Improve balance using Segway training

**Goal (in five words):** Improve balance using Segway training

**Official Title:** SegwayPD: The Effect of Sensory-augmented Postural Training Using Segway on Motor and Cognitive Function in Individuals With Parkinson's Disease

**Trial ID:** [NCT05982730](https://clinicaltrials.gov/study/NCT05982730)

## Key Facts

- **Phase:** NA
- **Status:** RECRUITING
- **Study Type:** INTERVENTIONAL
- **Sponsor:** University of Texas Southwestern Medical Center
- **Target Enrollment:** 15 participants
- **Start Date:** 2023-11-08
- **Completion Date:** 2026-07-31
- **Conditions:** Parkinson Disease
- **Interventions:** Sensory-Augmented Postural Training
- **Intervention Types:** BEHAVIORAL

## Summary For Families

The goal is to improve balance and related thinking skills in people with Parkinson's who have moderate balance problems, specifically those at Hoehn and Yahr stage III. The approach uses sensory-augmented postural training on a Segway-like platform, delivering controlled shifts and timed sensory cues that force small posture adjustments to retrain balance reflexes and sensory integration, which may help walking, reduce falls risk, and boost attention. Participants are adults 50 to 85 with idiopathic PD who have been on stable medication at least one month and can stand and walk unsupported for five minutes both on and off medication; people with other neurologic disorders, major unstable illnesses, or sensory or musculoskeletal problems that prevent training are excluded.

## Eligibility

- **Minimum age:** 50 Years
- **Maximum age:** 85 Years
- **Sex:** ALL

### Full Criteria

```
Inclusion Criteria:

* a clinical diagnosis of idiopathic PD with moderate disease stage presenting balance alterations (Hoehn and Yahr stage III)
* being stable on medication for at least 1 month
* the ability to stand and walk unsupported for 5 min both on and off medication
* age between 50 and 85

Exclusion Criteria:

* neurological disorders other than PD
* major unstable medical illnesses
* sensory or musculoskeletal disorders (e.g., diabetes, uncorrected visual problems, arthritis, severe hearing impairments) that will prohibit the ability to perform the assessment tests and receive training
```

## Locations (1)

- University of Texas Southwestern Medical Center, Dallas, Texas, United States _(32.7831, -96.8067)_
  - Yu-Chen Chung, Ph.D. — (CONTACT) — 626-551-7945 — yu-chen.chung@utsouthwestern.edu

## Central Contacts

- Yu-Chen Chung, PT, Ph.D. — (CONTACT) — 214-648-8838 — yu-chen.chung@utsouthwestern.edu
- Subaryani Soedirdjo, Ph.D. — (CONTACT) — subaryani.soedirdjo@utsouthwestern.edu

---

*Canonical: https://parkinsonspathways.com/trial/NCT05982730*  
*HTML version: https://parkinsonspathways.com/trial/NCT05982730*  
*Source data: https://clinicaltrials.gov/study/NCT05982730*